Microarray Gene Expression Profiling for Predicting Complete Response to Preoperative Chemoradiotherapy in Patients with Advanced Rectal Cancer
暂无分享,去创建一个
H. Choi | Seung-Yong Jeong | Jae-Hyun Park | K. Jung | H. Chang | Il-Jin Kim | Duck-Woo Kim | Jae‐Gahb Park | H. Kang | D. Sohn | D. Kim | Hye-won Park | S. Jang | Sun-A. Ahn | Seok-Byung Lim | Jae‐Hyun Park | Hye‐won Park | Duck-Woo Kim | H. Choi | Sang‐Geun Jang
[1] G. Noël,et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer , 2002 .
[2] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[3] H. Putter,et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. , 2001, The New England journal of medicine.
[4] Il-Jin Kim,et al. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations. , 2006, Carcinogenesis.
[5] Y. Okazaki,et al. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays. , 2005, International journal of oncology.
[6] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[7] S. Andreola,et al. Pathological features of rectal cancer after preoperative radiochemotherapy , 1998, International Journal of Colorectal Disease.
[8] P. Quirke,et al. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study , 2002, The Lancet.
[9] H. Blomgren,et al. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] D. Rothenberger,et al. A Pathologic Complete Response to Preoperative Chemoradiation Is Associated With Lower Local Recurrence and Improved Survival in Rectal Cancer Patients Treated by Mesorectal Excision , 2003, Diseases of the colon and rectum.
[11] Yusuke Nakamura,et al. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. , 2002, Neoplasia.
[12] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[13] Tae Hyun Kim,et al. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? , 2006, Cancer.
[14] Il-Jin Kim,et al. Microarray applications in cancer research. , 2004, Cancer research and treatment : official journal of Korean Cancer Association.
[15] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[16] T. Kim,et al. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[17] Il-Jin Kim,et al. Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide Microarrays , 2004, Clinical Cancer Research.
[18] David C. Atkins,et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] R. Herrmann,et al. STRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancer. , 2004, Neoplasia.
[20] H E Rockette,et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Bosset,et al. Role of Radiotherapy With Surgery for T3 and Resectable T4 Rectal Cancer: Evidence From Randomized Trials , 2006, Diseases of the colon and rectum.
[23] Trond Stokke,et al. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. , 2004, International journal of oncology.
[24] Andrew J. Wilson,et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. , 2003, Cancer research.
[25] P J Catalano,et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. , 2001, The New England journal of medicine.
[26] Norman Wolmark,et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] Yoko Yamamoto,et al. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. , 2006, Cancer research.
[29] H. Arai,et al. Microarray analysis of temporal gene responses to ionizing radiation in two glioblastoma cell lines: up-regulation of DNA repair genes. , 2004, Journal of radiation research.
[30] S. Larson,et al. Long-Term Prognostic Significance of Extent of Rectal Cancer Response to Preoperative Radiation and Chemotherapy , 2002, Annals of surgery.
[31] 大腸癌研究会. Japanese classification of colorectal carcinoma , 2009 .
[32] R. Simon,et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] B. Dörken,et al. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Rainer Fietkau,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.